Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CMND | PRESS-RELEASE | neutral | 2/10 | Clearmind Medicine's CEO participated in an invite-only federal policy summit at the National Press Club, convened by th | May 15, 2026 |
| STRR | PRESS-RELEASE | neutral | 2/10 | Star Equity Holdings declared a $0.25/share cash dividend on its 10% Series A Cumulative Perpetual Preferred Stock (STRR | May 15, 2026 |
| AIB | PRESS-RELEASE | mixed | 5/10 | BlockchAIn Digital Infrastructure reported Q1 2026 revenue of $4.9M (+9% YoY) but swung to a net loss of $0.3M vs net in | May 15, 2026 |
| BTCS | PRESS-RELEASE | bearish | 7/10 | BTCS reported Q1 2026 revenue of $2.1M (+27% YoY) and a net loss of $69.1M, driven by $35.7M in unrealized digital asset | May 15, 2026 |
| MBRX | PRESS-RELEASE | bearish | 6/10 | Moleculin Biotech reported Q1 2026 net loss of $12.8M ($3.54/share) vs $5.9M loss a year ago, with zero revenue. The EPS | May 15, 2026 |
| MENS | PRESS-RELEASE | neutral | 2/10 | Jyong Biotech filed its FY2025 annual report on Form 20-F, a routine regulatory milestone. The press release contains no | May 15, 2026 |
| DTST | PRESS-RELEASE | bearish | 5/10 | Data Storage Corp. reported Q1 2026 revenue of $346,707, up 10.9% from $312,744 YoY, and a net loss attributable to comm | May 15, 2026 |
| JTAI | PRESS-RELEASE | mixed | 5/10 | Jet.AI reported Q1 2026 revenue of $1.68M (beat consensus of $1.1M but down 51.6% YoY) and a massive EPS miss of -$6.68 | May 15, 2026 |
| HTCR | PRESS-RELEASE | bearish | 5/10 | HeartCore Enterprises reported Q1 2026 revenue of $1.2M, down 40.5% YoY from $2.1M, driven by declines in customized sof | May 15, 2026 |
| SLXN | PRESS-RELEASE | bearish | 7/10 | Silexion Therapeutics entered into warrant exercise agreements to raise ~$1M in gross proceeds, issuing new Series C and | May 15, 2026 |
| JZXN | PRESS-RELEASE | neutral | 3/10 | Jiuzi Holdings announced a non-binding MoU with an unnamed AI technology company to collaborate on AI-driven imaging, cl | May 15, 2026 |
| WALD | PRESS-RELEASE | neutral | 4/10 | Obagi Medical, a Waldencast subsidiary, presented interim clinical and real-world data at the Music City SCALE meeting f | May 15, 2026 |
| SPAI | PRESS-RELEASE | bullish | 6/10 | Safe Pro Group reported Q1 2026 revenue of $1.22M, up 560% YoY, driven by AI-powered drone analysis product sales. Gross | May 15, 2026 |
| DY | PRESS-RELEASE | neutral | 2/10 | Dycom Industries announced it will host a conference call on May 27, 2026, to discuss fiscal 2027 first quarter results, | May 15, 2026 |
| PESI | PRESS-RELEASE | bearish | 6/10 | Perma-Fix Environmental Services priced an underwritten public offering of 2,285,714 shares at $8.75 per share, expectin | May 15, 2026 |
| GALT | PRESS-RELEASE | bullish | 6/10 | Galectin Therapeutics reported Q1 2026 EPS of -$0.08, missing consensus of -$0.06 (-33.3% miss), but highlighted positiv | May 15, 2026 |
| LFWD | PRESS-RELEASE | bearish | 7/10 | Lifeward reported Q1 2026 revenue of $3.9M (down 22% YoY) and a GAAP net loss of $10.8M ($6.70/share), massively missing | May 15, 2026 |
| OBAI | PRESS-RELEASE | bearish | 6/10 | OBAI reported Q1 2026 revenue of $2.3M (+4.36% YoY) but net loss tripled to $6.7M, driven by a surge in operating expens | May 15, 2026 |
| BCDA | PRESS-RELEASE | mixed | 6/10 | BioCardia reported Q1 2026 EPS of -$0.21, missing consensus of -$0.17 by 23.5%, while revenue remained zero. However, th | May 15, 2026 |
| COCP | PRESS-RELEASE | neutral | 5/10 | Cocrystal Pharma reported Q1 2026 EPS of -$0.17, missing consensus of -$0.15 by 13.3%, and recognized $225k in grant rev | May 15, 2026 |
| ATYR | PRESS-RELEASE | neutral | 5/10 | aTyr Pharma reported Q1 2026 EPS of -$0.14, a 3.9% beat vs consensus of -$0.15, on no revenue. The company announced pla | May 15, 2026 |
| CGON | PRESS-RELEASE | bullish | 6/10 | CG Oncology announced positive Phase 2 data for cretostimogene + gemcitabine in high-risk NMIBC, showing 89.5% HG-EFS at | May 15, 2026 |
| IMRX | PRESS-RELEASE | bullish | 7/10 | Immuneering reported Q1 2026 EPS of -$0.21, beating consensus of -$0.25 by 16%, with no revenue. The key catalyst is upc | May 15, 2026 |
| AXG | PRESS-RELEASE | bullish | 5/10 | Solowin Holdings (AXG) announced a non-binding MOU between its AX Coin stablecoin subsidiary and Infinios Financial Serv | May 15, 2026 |
| PFSA | PRESS-RELEASE | neutral | 4/10 | Profusa announced it will be listed on the Nasdaq Capital Market effective May 15, 2026, as the first milestone in a com | May 15, 2026 |
| JOYY | PRESS-RELEASE | neutral | 1/10 | JOYY Inc. announced it will report its Q1 2026 results on May 25, 2026. | May 15, 2026 |
| SLE | PRESS-RELEASE | bearish | 7/10 | Super League Enterprise reported Q1 2026 EPS of $-9.44, a massive 391.7% miss vs consensus of $-1.92, and revenue of $3. | May 15, 2026 |
| EDBL | PRESS-RELEASE | bearish | 6/10 | Edible Garden reported Q1 2026 revenue of $3.3M (+22.9% YoY), driven by 46% growth in cut herbs and expansion into highe | May 15, 2026 |
| INKT | PRESS-RELEASE | bullish | 6/10 | MiNK Therapeutics reported Q1 2026 EPS of -$0.57, beating consensus of -$0.77 by 26%, with net loss narrowing to $2.7M f | May 15, 2026 |
| RENX | PRESS-RELEASE | bearish | 7/10 | RenX Enterprises reported Q1 2026 revenue of $3.96M, up ~20.5% QoQ from $3.28M, but posted a GAAP net loss of $9.33M dri | May 15, 2026 |